trending Market Intelligence /marketintelligence/en/news-insights/trending/4bxzm0EdnFHYmGK7NSg6zA2 content esgSubNav
In This List

China Biologic to acquire 80% stake in PW Medtech unit

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


China Biologic to acquire 80% stake in PW Medtech unit

China Biologic Products Holdings Inc. said it will acquire PW Medtech Group Ltd.'s 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co. Ltd.

China Biologic will issue 5,521,000 ordinary shares to PW Medtech in return for the equity in Tianxinfu. As a result, PWM will end up owning a 16.66% share in China Biologic.

The transaction is expected to close this year.

PW Medtech recently sold a 20% stake in Tianxinfu to Xinyu Yongshuo Management and Consulting LLP and was considering a spinoff and separate listing of the entity on the Shenzhen or Shanghai stock exchanges.